ADVFN Logo ADVFN

Hot Features

Registration Strip Icon for monitor ブラジル証券取引所、NASDAQ、NYSE、AMEX、LSEなどの主要取引所からの複数のリアルタイム株価を監視します。

GOVX GeoVax Labs Inc

1.61
0.19 (13.38%)
2024年5月4日 - 終了
15分遅延
名称 銘柄コード 市場 種別
GeoVax Labs Inc GOVX NASDAQ 普通株式
  前日比 前日比 % 現在値 時刻
0.19 13.38% 1.61 13:00:05
始値 安値 高値 終値 前日終値
1.42 1.42 1.70 1.61 1.42
この銘柄の詳細情報 »

最新ニュース

日付 時間 ソース タイトル
2024/4/0501:30GLOBEGeoVax Presents Data on GEO-CM04S1, a Next Generation..
2024/3/2822:00GLOBEGeoVax to Present Data on GEO-CM04S1, a Next Generation..
2024/3/1222:00GLOBEGeoVax to Present at the 36th Annual Roth Conference
2024/3/1205:13EDGAR2Form 10-K/A - Annual report [Section 13 and 15(d), not S-K..
2024/3/1113:15EDGAR2Form EFFECT - Notice of Effectiveness
2024/3/0623:00GLOBEGeoVax Achieves Milestone in Transition to Commercially..
2024/3/0206:08EDGAR2Form S-3 - Registration statement under Securities Act of..
2024/3/0106:05EDGAR2Form 10-K - Annual report [Section 13 and 15(d), not S-K..
2024/3/0106:00GLOBEGeoVax Reports 2023 Year-End Financial Results and Provides..
2024/2/2306:41EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/2/2223:00GLOBEGeoVax to Report 2023 Financial Results and Provide..
2024/2/1923:00GLOBEGeoVax to Present at the 2024 BIO CEO & Investor Conference
2024/2/1706:01EDGAR2Form 8-K - Current report
2024/2/1505:38EDGAR2Form SC 13G - Statement of acquisition of beneficial..
2024/2/1323:00GLOBEGeoVax Announces Multiple Patent Issuances and Allowances
2024/2/0806:43EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/2/0623:00GLOBEGeoVax Reports Positive Interim Data From Phase 2 Clinical..
2024/2/0103:13EDGAR2Form 8-K - Current report
2024/1/2923:00GLOBEGeoVax Announces 1-for-15 Reverse Stock Split to Regain..
2024/1/1706:03EDGAR2Form 8-K - Current report
2024/1/1306:00EDGAR2Form 424B3 - Prospectus [Rule 424(b)(3)]
2024/1/0823:00GLOBEGeoVax Appoints Dr. Marc Pipas as Executive Medical..
2024/1/0423:00GLOBEGeoVax Announces Gedeptin® Patient Enrollment Closure for..
2024/1/0323:00GLOBEGeoVax Announces Issuance of Malaria Vaccine Patent
2024/1/0306:10EDGAR2Form S-1 - General form for registration of securities under..
2023/12/2723:00GLOBEGeoVax to Present at Biotech Showcase During J.P. Morgan..
2023/12/2705:51EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2023/12/1923:00GLOBEGeoVax Expands Rights Under NIH COVID-19 License to Include..
2023/12/0906:02EDGAR2Form 8-K - Current report
2023/12/0422:00EDGAR2Form 8-K - Current report
2023/12/0106:30GLOBEGeoVax Hemorrhagic Fever Vaccine Data Presented at World..
2023/11/2923:00GLOBEGeoVax to Participate in Upcoming December Investor Events
2023/11/2823:00GLOBEGeoVax COVID-19 Vaccine Clinical Data Presented at World..
2023/11/2806:06EDGAR2Form DEF 14A - Other definitive proxy statements
2023/11/1806:27EDGAR2Form PRE 14A - Other preliminary proxy statements
2023/11/1423:00GLOBEProgress on GeoVax’s Universal Coronavirus Vaccine..
2023/11/1002:40EDGAR2Form 8-K - Current report
2023/11/0906:04EDGAR2Form 424B3 - Prospectus [Rule 424(b)(3)]
2023/11/0906:03EDGAR2Form 424B3 - Prospectus [Rule 424(b)(3)]
2023/11/0906:01EDGAR2Form 424B3 - Prospectus [Rule 424(b)(3)]
2023/11/0906:00EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2023/11/0906:00GLOBEGeoVax Reports Third Quarter 2023 Financial Results and..
2023/10/3122:00GLOBEGeoVax to Report Third Quarter 2023 Financial Results and..
2023/10/3022:00GLOBEGeoVax Commences Site Expansion for Phase 2 Trial of..
2023/10/2522:00GLOBEGeoVax to Participate in Upcoming November Investor and..
2023/10/2422:00GLOBEGeoVax Update: Clinical and Operational Progress Toward..
2023/10/0922:00GLOBEGeoVax Receives Notice of Allowance for Marburg Vaccine..
2023/10/0522:00GLOBEGeoVax Receives Notice of Allowance for HIV Vaccine Patent
2023/9/2805:33EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2023/9/2722:00GLOBEGeoVax to Participate in Upcoming October Investor and..

最近閲覧した銘柄

Delayed Upgrade Clock